Level Bio ABFRA:4MB +8.00%23 Gross Margin % is 53.89% as of Mar. 2026, which is 22% above its 10-year median of 44.35. GuruFocus rates FRA:4MB with a GF Score™ of 23/100. The stock has 4 warning signs investors should review. Among 195 Medical Diagnostics & Research companies, Level Bio AB ranks better than 53.33% on this metric.
The historical rank and industry rank for Level Bio AB's Gross Margin % or its related term are showing as below:
FRA:4MB'
s Gross Margin % Range Over the Past 10 Years
Min: 38.83 Med: 44.35 Max: 53.77
Current: 53.64
During the past 13 years, the highestGross Margin % of Level Bio AB was 53.77%. The lowest was 38.83%. And the median was 44.35%.
FRA:4MB's Gross Margin % is ranked better than 53.33% of 195
companies
in the Medical Diagnostics & Research industry
Industry Median: 50.97
vs FRA:4MB: 53.64
Level Bio AB had a gross margin of 53.89% for the quarter that ended in Mar. 2026 => Durable competitive advantage
The 5-Year average Growth Rate of Gross Margin for Level Bio AB was 7.20% per year.
Level Bio AB (FRA:4MB) Gross Margin % Explanation
Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.
Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %
1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key
Level Bio AB had a gross margin of 53.89% for the quarter that ended in Mar. 2026 => Durable competitive advantage
Be Aware
If a company loses its competitive advantages, usually its gross margin declines well before its sales declines. Watching Gross Margin % and Operating Margin % closely helps avoid value trap situations.
Level Bio AB Gross Margin % Related Terms
Level Bio AB Gross Margin % Historical Data
* Premium members only.
The historical data trend for Level Bio AB's Gross Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
FRA:4MB vs TMO, DHR, IDXX: Gross Margin % Comparison
For the Diagnostics & Research subindustry, Level Bio AB's Gross Margin %, along with its competitors' market caps and Gross Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Level Bio AB Gross Margin % vs Medical Diagnostics & Research Industry
For the Medical Diagnostics & Research industry and Healthcare sector, Level Bio AB's Gross Margin % distribution charts can be found below:
* The bar in red indicates where Level Bio AB's Gross Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.
Level Bio AB (FRA:4MB) has a Gross Margin % of 53.89% as of Mar. 2026. Gross margin is the ratio of total gross profit to net sales. View historical data on Level Bio AB and its competitors. This is 22% above median its historical median of 44.35. Over the past decade, Level Bio AB's Gross Margin % has ranged from 38.83 to 53.77. According to the industry distribution chart, Level Bio AB ranks #91 out of 195 companies in the Medical Diagnostics & Research industry, placing it in the top 46.7%.
Is Level Bio AB's Gross Margin % too high?
Level Bio AB's current Gross Margin % of 53.89% is 22% above median its 10-year median of 44.35. Over the past 10 years, this metric has ranged from a low of 38.83 to a high of 53.77. The Medical Diagnostics & Research industry median Gross Margin % is 50.97. Level Bio AB's value of 53.89% is 5.7% above this industry median. Based on the distribution chart, Level Bio AB ranks #91 out of 195 companies in the Medical Diagnostics & Research industry, which is above the industry midpoint. Overall, Level Bio AB has a GF Score™ of 23/100, reflecting its overall financial health beyond just this single metric.
How does Level Bio AB's Gross Margin % compare to TMO and DHR?
According to the Medical Diagnostics & Research industry distribution chart, Level Bio AB ranks #91 out of 195 companies for Gross Margin %. This puts Level Bio AB in the upper half of its industry. The industry median Gross Margin % is 50.97. Level Bio AB's value of 53.89% is 5.7% above this benchmark. Historically, Level Bio AB's own Gross Margin % has ranged from 38.83 to 53.77 over the past decade. While the company's 10-year median is 44.35 vs. the industry median of 50.97, Level Bio AB has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Gross Margin % for a Medical Diagnostics & Research company?
The median Gross Margin % among Medical Diagnostics & Research companies is 50.97, based on 195 companies in the industry. Companies in the top quartile (top 25%) have a Gross Margin % significantly above this median, while those in the bottom quartile fall well below. However, Gross Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Level Bio AB's current Gross Margin % of 53.89% is 5.7% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Gross Margin % mean?
A high Gross Margin % can signal that a stock is expensive relative to its fundamentals. Gross margin is the ratio of total gross profit to net sales. View historical data on Level Bio AB and its competitors. For the Medical Diagnostics & Research industry, the median Gross Margin % is 50.97 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Level Bio AB's current Gross Margin % is 53.89%, which is 22% above median its own 10-year median of 44.35. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Level Bio AB stock overvalued right now?
Level Bio AB (FRA:4MB) has a current Gross Margin % of 53.89%. The current Gross Margin % is 53.89%, which is 22% above median its 10-year median of 44.35 and 5.7% above the Medical Diagnostics & Research industry median of 50.97. Level Bio AB's overall GF Score™ is 23/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Gross Margin % calculated?
Gross Margin % is calculated from a company's financial statements. For Level Bio AB (FRA:4MB), the current Gross Margin % is 53.89% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Level Bio AB is a parent company and operates through subsidiary. It develops and manufactures diagnostic kits for the clinical market and also is a distributor and full service partner to molecular biology labs in the Nordics.
23GF Score
Get the complete analysis for FRA:4MB
Gross Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:4MB has been successfully added to your 
